Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy
出版年份 2021 全文链接
标题
Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy
作者
关键词
-
出版物
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 12, Pages 7963-7990
出版商
American Chemical Society (ACS)
发表日期
2021-06-09
DOI
10.1021/acs.jmedchem.1c00100
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Selective Inhibition of the Hsp90a isoform
- (2021) Brian Blagg et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- CAP rigidification of MS-275 and chidamide leads to enhanced antiproliferative effects mediated through HDAC1, 2 and tubulin polymerization inhibition
- (2021) Arshdeep Singh et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Enhanced antitumor potential induced by chloroacetate-loaded benzophenones acting as fused tubulin-pyruvate dehydrogenase kinase 1 (PDHK1) ligands
- (2020) Alina Ghinet et al. BIOORGANIC CHEMISTRY
- Dual-functional conjugates improving cancer immunochemotherapy by inhibiting tubulin polymerization and indoleamine-2,3-dioxygenase
- (2020) Shixian Hua et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis, and evaluation of N-phenyl-4-(2-phenylsulfonamido)-benzamides as microtubule-targeting agents in drug-resistant cancer cells, displaying HDAC inhibitory response
- (2020) Wei-Cheng Wu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Dual-target kinase drug design: Current strategies and future directions in cancer therapy
- (2020) Dejuan Sun et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Novel Dual-Target Inhibitor of ERK1 and ERK5 That Induces Regulated Cell Death to Overcome Compensatory Mechanism in Specific Tumor Types
- (2020) Guan Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- New techniques and strategies in drug discovery
- (2020) Jintong Du et al. CHINESE CHEMICAL LETTERS
- Discovery of a Dual Tubulin Polymerization and Cell Division Cycle 20 Homologue Inhibitor via Structural Modification on Apcin
- (2020) Pan Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Perspective on Multi-target Drugs for Alzheimer’s Disease
- (2020) Ondrej Benek et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Design, synthesis, and biological evaluation of quinazolin-4(3H)-one derivatives co-targeting poly(ADP-ribose) polymerase-1 and bromodomain containing protein 4 for breast cancer therapy
- (2020) Xiaosa Chang et al. Acta Pharmaceutica Sinica B
- Development of SKI-349, a dual-targeted inhibitor of sphingosine kinase and microtubule polymerization
- (2020) Jeremy A. Hengst et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Indolizine-phenothiazine hybrids as the first dual inhibitors of tubulin polymerization and farnesyltransferase with synergistic antitumor activity
- (2020) Iuliana-Monica Moise et al. BIOORGANIC CHEMISTRY
- Design, Synthesis and Screening of Benzimidazole Containing Compounds with Methoxylated Aryl Radicals as Cytotoxic Molecules on (HCT-116) Colon Cancer Cells
- (2020) Ryad et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Natural and Semisynthetic Chalcones as Dual FLT3 and Microtubule Polymerization Inhibitors
- (2020) Haleema Sadia Malik et al. JOURNAL OF NATURAL PRODUCTS
- A Novel Cytotoxic Conjugate Derived from the Natural Product Podophyllotoxin as a Direct-Target Protein Dual Inhibitor
- (2020) Ángela-Patricia Hernández et al. MOLECULES
- Drug repositioning and repurposing for Alzheimer disease
- (2020) Clive Ballard et al. Nature Reviews Neurology
- Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
- (2020) Monica Phimmachanh et al. Frontiers in Cell and Developmental Biology
- Oxazole-Bridged Combretastatin A-4 Derivatives with Tethered Hydroxamic Acids: Structure–Activity Relations of New Inhibitors of HDAC and/or Tubulin Function
- (2019) Florian Schmitt et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2-d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors
- (2019) Romeo Romagnoli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pocket similarity identifies selective estrogen receptor modulators as microtubule modulators at the taxane site
- (2019) Yu-Chen Lo et al. Nature Communications
- Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy
- (2019) Kinsie E Arnst et al. MEDICINAL RESEARCH REVIEWS
- Cink4T, a quinazolinone-based dual inhibitor of Cdk4 and tubulin polymerization, identified via ligand-based virtual screening, for efficient anticancer therapy
- (2019) Vinay Sonawane et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Multifunctional platinum(IV) complexes as immunostimulatory agents to promote cancer immunochemotherapy by inhibiting tryptophan-2,3-dioxygenase
- (2019) Shixian Hua et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel conjugates of podophyllotoxin and coumarin: Synthesis, cytotoxicities, cell cycle arrest, binding CT DNA and inhibition of Topo IIβ
- (2019) Shu-Yi Hao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Anti-tumor activity evaluation of novel tubulin and HDAC dual-targeting inhibitors
- (2019) Baolei Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design, synthesis, antitumor activities and biological studies of novel diaryl substituted fused heterocycles as dual ligands targeting tubulin and katanin
- (2019) Feng Gao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer
- (2019) Yohei Sekino et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dual-targeting antitumor conjugates derived from platinum(IV) prodrugs and microtubule inhibitor CA-4 significantly exhibited potent ability to overcome cisplatin resistance
- (2019) Xiaochao Huang et al. BIOORGANIC CHEMISTRY
- Introducing of acyclonucleoside analogues tethered 1,2,4-triazole as anticancer agents with dual epidermal growth factor receptor kinase and microtubule inhibitors
- (2019) Mohamed Reda Aouad et al. BIOORGANIC CHEMISTRY
- Benzothienoquinazolinones as new multi-target scaffolds: Dual inhibition of human Topoisomerase I and tubulin polymerization
- (2019) Jessica Ceramella et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Reversible binding of the anticancer drug KXO1 (tirbanibulin) to the colchicine-binding site of β-tubulin explains KXO1's low clinical toxicity
- (2019) Lu Niu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Microtubule inhibitors containing immunostimulatory agents promote cancer immunochemotherapy by inhibiting tubulin polymerization and tryptophan-2,3-dioxygenase
- (2019) Shixian Hua et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Antiproliferative activity of diarylnaphthylpyrrolidine derivative via dual target inhibition
- (2019) Amit Kumar Verma et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer
- (2019) Lei Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pt(IV) complexes conjugating with chalcone analogue as inhibitors of microtubule polymerization exhibited selective inhibition in human cancer cells
- (2018) Xiaochao Huang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Dual-targeting antitumor hybrids derived from Pt(IV) species and millepachine analogues
- (2018) Xiaochao Huang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pt(IV) prodrugs containing microtubule inhibitors displayed potent antitumor activity and ability to overcome cisplatin resistance
- (2018) Lingxue Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel Dual Mechanism of Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-361)
- (2018) Michael P. Smolinski et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on isocombretastatin A-4
- (2018) Diana Lamaa et al. JOURNAL OF MEDICINAL CHEMISTRY
- SKLB-23bb, A HDAC6-Selective Inhibitor, Exhibits Superior and Broad-Spectrum Antitumor Activity via Additionally Targeting Microtubules
- (2018) Fang Wang et al. MOLECULAR CANCER THERAPEUTICS
- Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
- (2018) Mark A. Socinski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Microtubule-Targeting Agents: Strategies To Hijack the Cytoskeleton
- (2018) Michel O. Steinmetz et al. TRENDS IN CELL BIOLOGY
- Design, synthesis and biological evaluation of a novel library of antimitotic C2-aroyl/arylimino tryptamine derivatives that are also potent inhibitors of indoleamine-2, 3-dioxygenase (IDO)
- (2018) Jyoti Chauhan et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
- (2018) Ewgenij Proschak et al. JOURNAL OF MEDICINAL CHEMISTRY
- KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma
- (2018) Michael J. Ciesielski et al. JOURNAL OF NEURO-ONCOLOGY
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
- (2018) Luis Paz-Ares et al. NEW ENGLAND JOURNAL OF MEDICINE
- 1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase
- (2018) Mei-Jung Lai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Antitubulin sulfonamides: The successful combination of an established drug class and a multifaceted target
- (2018) Alba Vicente-Blázquez et al. MEDICINAL RESEARCH REVIEWS
- Artificial Intelligence in Drug Design
- (2018) Gerhard Hessler et al. MOLECULES
- Artificial Intelligence in Drug Design—The Storm Before the Calm?
- (2018) Allan M. Jordan ACS Medicinal Chemistry Letters
- 3-Aroylindoles display antitumor activity in vitro and in vivo: Effects of N1-substituents on biological activity
- (2017) Hsueh-Yun Lee et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells
- (2017) Ana Podolski-Renić et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Microtubule Depolymerization by Kinase Inhibitors: Unexpected Findings of Dual Inhibitors
- (2017) Kenji Tanabe INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Taxol®: The First Microtubule Stabilizing Agent
- (2017) Chia-Ping Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Computational Multitarget Drug Design
- (2017) Weilin Zhang et al. Journal of Chemical Information and Modeling
- The Search for Potent, Small-Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat
- (2017) Chiara Zagni et al. MEDICINAL RESEARCH REVIEWS
- Combined CRISPRi/a-Based Chemical Genetic Screens Reveal that Rigosertib Is a Microtubule-Destabilizing Agent
- (2017) Marco Jost et al. MOLECULAR CELL
- Deconvolution of Buparlisib’s mechanism of action defines specific PI3K and tubulin inhibitors for therapeutic intervention
- (2017) Thomas Bohnacker et al. Nature Communications
- Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis
- (2017) Seongyeong Kim et al. Cancer Research and Treatment
- Combretastatin A-4 Analogue: A Dual-Targeting and Tubulin Inhibitor Containing Antitumor Pt(IV) Moiety with a Unique Mode of Action
- (2016) Xiaochao Huang et al. BIOCONJUGATE CHEMISTRY
- A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling
- (2016) Sai Krishna Athuluri-Divakar et al. CELL
- The importance of predictive biomarkers in oncology drug development
- (2016) Jan Trøst Jørgensen EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Dual-targeting hybrid peptide-conjugated doxorubicin for drug resistance reversal in breast cancer
- (2016) Yuan Sheng et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Purine-Type Compounds Induce Microtubule Fragmentation and Lung Cancer Cell Death through Interaction with Katanin
- (2016) Ting-Chun Kuo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth
- (2016) María-Jesús Pérez-Pérez et al. JOURNAL OF MEDICINAL CHEMISTRY
- 2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibition
- (2016) Kunal Nepali et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Network pharmacology of cancer: From understanding of complex interactomes to the design of multi-target specific therapeutics from nature
- (2016) Paramasivan Poornima et al. PHARMACOLOGICAL RESEARCH
- The design, synthesis and biological evaluation of conformationally restricted 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multi-targeted receptor tyrosine kinase and microtubule inhibitors as potential antitumor agents
- (2015) Xin Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Mechanistic Origin of Microtubule Dynamic Instability and Its Modulation by EB Proteins
- (2015) Rui Zhang et al. CELL
- Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors
- (2015) Xuan Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Taxane anticancer agents: a patent perspective
- (2015) Iwao Ojima et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery
- (2015) Yuxi Wang et al. FEBS Journal
- Photoaffinity labeling in target- and binding-site identification
- (2015) Ewan Smith et al. Future Medicinal Chemistry
- The synergic effect of vincristine and vorinostat in leukemia in vitro and in vivo
- (2015) Min-Wu Chao et al. Journal of Hematology & Oncology
- How Beyond Rule of 5 Drugs and Clinical Candidates Bind to Their Targets
- (2015) Bradley C. Doak et al. JOURNAL OF MEDICINAL CHEMISTRY
- Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents
- (2015) Shengzheng Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy
- (2015) Samuel G. Awuah et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Bevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor Response
- (2015) M. Cesca et al. MOLECULAR CANCER THERAPEUTICS
- Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins
- (2015) Marianne S. Poruchynsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dual targeting of microtubule and topoisomerase II by α-carboline derivative YCH337 for tumor proliferation and growth inhibition
- (2015) Jun-Mei Yi et al. Oncotarget
- Small molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancer
- (2015) Seth A. Brodie et al. Oncotarget
- Multi-target pharmacology: possibilities and limitations of the “skeleton key approach” from a medicinal chemist perspective
- (2015) Alan Talevi Frontiers in Pharmacology
- Identification of DW532 as a novel anti-tumor agent targeting both kinases and tubulin
- (2014) Ting Peng et al. ACTA PHARMACOLOGICA SINICA
- The design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agents
- (2014) Xin Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Belinostat: First Global Approval
- (2014) Raewyn M. Poole DRUGS
- Polypharmacology: the rise of multitarget drugs over combination therapies
- (2014) Michela Rosini Future Medicinal Chemistry
- Rigosertib Is a More Effective Radiosensitizer Than Cisplatin in Concurrent Chemoradiation Treatment of Cervical Carcinoma, In Vitro and In Vivo
- (2014) Lorenzo Agoni et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The contribution of αβ-tubulin curvature to microtubule dynamics
- (2014) Gary J. Brouhard et al. JOURNAL OF CELL BIOLOGY
- Strategies for modern biomarker and drug development in oncology
- (2014) Alan D Smith et al. Journal of Hematology & Oncology
- β-Lactam Estrogen Receptor Antagonists and a Dual-Targeting Estrogen Receptor/Tubulin Ligand
- (2014) Niamh M. O’Boyle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Polypharmacology: Challenges and Opportunities in Drug Discovery
- (2014) Andrew Anighoro et al. JOURNAL OF MEDICINAL CHEMISTRY
- P-Glycoprotein-Evading Anti-tumor Activity of a Novel Tubulin and HSP90 Dual Inhibitor in a Non-small-cell Lung Cancer Model
- (2014) Qiu Zhang et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Phenotypic screening in cancer drug discovery — past, present and future
- (2014) John G. Moffat et al. NATURE REVIEWS DRUG DISCOVERY
- Discovery of Antitubulin Agents with Antiangiogenic Activity as Single Entities with Multitarget Chemotherapy Potential
- (2014) Aleem Gangjee et al. ACS Medicinal Chemistry Letters
- The role of dynamic instability in microtubule organization
- (2014) Tetsuya Horio et al. Frontiers in Plant Science
- Anti-tumor selectivity of a novel Tubulin and HSP90 dual-targeting inhibitor in non-small cell lung cancer models
- (2013) Qiu Zhang et al. BIOCHEMICAL PHARMACOLOGY
- The discovery of colchicine-SAHA hybrids as a new class of antitumor agents
- (2013) Xuan Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Cytotoxic Activity of Tivantinib (ARQ 197) Is Not Due Solely to c-MET Inhibition
- (2013) R. Katayama et al. CANCER RESEARCH
- The Binding Sites of Microtubule-Stabilizing Agents
- (2013) Jessica J. Field et al. CHEMISTRY & BIOLOGY
- Targeting Src and Tubulin in Mucinous Ovarian Carcinoma
- (2013) T. Liu et al. CLINICAL CANCER RESEARCH
- Polypharmacology in a Single Drug: Multitarget Drugs
- (2013) M. L. Bolognesi CURRENT MEDICINAL CHEMISTRY
- Mechanisms regulating resistance to inhibitors of topoisomerase II
- (2013) Ram N. Ganapathi et al. Frontiers in Pharmacology
- Phase 1 dose-escalation trial evaluating the combination of the selective MET (mesenchymal-epithelial transition factor) inhibitor tivantinib (ARQ 197) plus erlotinib
- (2012) Jonathan W. Goldman et al. CANCER
- Microtubule-severing enzymes at the cutting edge
- (2012) D. J. Sharp et al. JOURNAL OF CELL SCIENCE
- Synthesis and Biological Evaluation of 1,4-Diaryl-2-azetidinones as Specific Anticancer Agents: Activation of Adenosine Monophosphate Activated Protein Kinase and Induction of Apoptosis
- (2012) Farida Tripodi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Peptidomimetic Src/Pretubulin Inhibitor KX-01 Alone and in Combination with Paclitaxel Suppresses Growth, Metastasis in Human ER/PR/HER2-Negative Tumor Xenografts
- (2012) M. Anbalagan et al. MOLECULAR CANCER THERAPEUTICS
- Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
- (2012) L. Pilotte et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer
- (2011) Muralidharan Anbalagan et al. BREAST CANCER RESEARCH AND TREATMENT
- Low-dose drug combinations along molecular pathways could maximize therapeutic effectiveness while minimizing collateral adverse effects
- (2011) Jörn Lötsch et al. DRUG DISCOVERY TODAY
- Discovery of a Novel Mode of Protein Kinase Inhibition Characterized by the Mechanism of Inhibition of Human Mesenchymal-epithelial Transition Factor (c-Met) Protein Autophosphorylation by ARQ 197
- (2011) Sudharshan Eathiraj et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of a Clinical Stage Multi-Kinase Inhibitor Sodium (E)-2-{2-Methoxy-5-[(2′,4′,6′-trimethoxystyrylsulfonyl)methyl]phenylamino}acetate (ON 01910.Na): Synthesis, Structure–Activity Relationship, and Biological Activity
- (2011) M. V. Ramana Reddy et al. JOURNAL OF MEDICINAL CHEMISTRY
- From in silico target prediction to multi-target drug design: Current databases, methods and applications
- (2011) Alexios Koutsoukas et al. Journal of Proteomics
- Drugs that target dynamic microtubules: A new molecular perspective
- (2011) Richard A. Stanton et al. MEDICINAL RESEARCH REVIEWS
- Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor
- (2011) S.-M. Maira et al. MOLECULAR CANCER THERAPEUTICS
- Early Clinical Development of ARQ 197, a Selective, Non-ATP-Competitive Inhibitor Targeting MET Tyrosine Kinase for the Treatment of Advanced Cancers
- (2011) A. A. Adjei et al. ONCOLOGIST
- An Interaction Network Predicted from Public Data as a Discovery Tool: Application to the Hsp90 Molecular Chaperone Machine
- (2011) Pablo C. Echeverría et al. PLoS One
- Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel In Vitro and In Vivo
- (2011) Valentina Zuco et al. PLoS One
- Aberrant expression of katanin p60 in prostate cancer bone metastasis
- (2011) Xiangcang Ye et al. PROSTATE
- ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity
- (2010) N. Munshi et al. MOLECULAR CANCER THERAPEUTICS
- Microtubule-binding agents: a dynamic field of cancer therapeutics
- (2010) Charles Dumontet et al. NATURE REVIEWS DRUG DISCOVERY
- Discovery of Dual VEGFR-2 and Tubulin Inhibitors with in Vivo Efficacy
- (2010) Eugene L. Piatnitski Chekler et al. ACS Medicinal Chemistry Letters
- Tubulin: A Target for Antineoplastic Drugs into the Cancer Cells but also in the Peripheral Nervous System
- (2009) Annalisa Canta et al. CURRENT MEDICINAL CHEMISTRY
- Histone Deacetylase Inhibitors
- (2009) Xujun Ma et al. DRUGS
- Integration of Ligand and Structure-Based Virtual Screening for the Identification of the First Dual Targeting Agent for Heat Shock Protein 90 (Hsp90) and Tubulin
- (2009) Andrew J. S. Knox et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial
- (2009) Noriyuki Katsumata et al. LANCET
- Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance
- (2009) E. A. Perez MOLECULAR CANCER THERAPEUTICS
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase III, Double-Blind, Randomized Study Comparing Lapatinib Plus Paclitaxel With Placebo Plus Paclitaxel As First-Line Treatment for Metastatic Breast Cancer
- (2008) Angelo Di Leo et al. JOURNAL OF CLINICAL ONCOLOGY
- Naturally Occurring Homoisoflavonoids Function as Potent Protein Tyrosine Kinase Inhibitors by c-Src-Based High-Throughput Screening
- (2008) Li-Gen Lin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
- (2008) Andrea Cavalli et al. JOURNAL OF MEDICINAL CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started